Analysis of Novel Cannabis Products Labeled as Containing THC-JD

THC-JD (tetrahydrocannabioctyl) is a semi-synthetic cannabinoid with an eight-carbon C3 side chain, present in only trace amounts in hemp, requiring synthesis for commercial use. It has been promoted as potentially 19 times more potent than Δ⁹-THC, consistent with enhanced CB1 receptor affinities for cannabinoids with 7-8 carbon C3 side chains. While one peer-reviewed report identified THC-JD (tetrahydrocannabioctyl) in Japanese online products, an anecdotal report from the U.S. suggests mislabeling.

To inform regulatory efforts and consumer awareness and to address these discrepancies, this study chemically analyzed five U.S. commercial cannabis vape products marketed as containing THC-JD.

Utilizing GC-MS analysis with a Δ⁸-THC-JD reference standard, no THC-JD was detected in any of the five commercial samples. Instead, the most prevalent compound in four of the five samples was Δ⁸-THC.

The absence of THC-JD in these products raises critical concerns for consumer safety, regulatory compliance, and industry integrity, as consumers risk unknowingly ingesting uncharacterized or mislabeled substances. The lack of standardization in THC-JD products raises critical concerns for regulatory compliance and industry integrity. Further studies are needed to characterize THC-JD products and evaluate their potential health risk to consumers.